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ABSTRACT Oct factors are members ofthe POU family of
transcription factors that are shown to play important roles
during development in mammals. Here we report the cDNA
clonin and expression ofaDrosophila Oct transcription factor.
Whole mount in situ hybridization experiments revealed that
the spatial expression patterns of this gene during embryonic
development have not yet been observed for any other gene. In
early embryogenesis, its transcripts are transently expressed
as a wide uniform band from 20% to 40% of the egg length,
very similar to that of gap genes. This pattern progressively
resolves into a series ofnarrower stripes followed by expression
in 14 stripes. Subsequently, transcripts from this gene are
expressed in the central nervous system and the brain. When
expressed in the yeast Sacclwromyces cerevisiae, this Drosoph-
la factor functions as a strong, octamer-dependent activator of
transcription. Our data strongly suggest possible functions for
the Oct factor in pattern formation in Drosophila that might
transcend the boundaries of genetically defined segmentation
genes.
Classical and molecular genetic analyses in Drosophila have
postulated that complex networks of developmental regula-
tors form a cascade with a determined hierarchy that guides
the transfer ofgenetic information into embryonic structures.
Several genes that encode such regulators have been cloned
and many of them have been found to encode proteins that
contain a conserved domain called the homeodomain. Ho-
meodomain proteins have been shown to bind to specific
DNA sequences and function as transcription regulators in
vitro, in tissue culture and yeast cells, and in the Drosophila
embryo (reviewed in refs. 1 and 2). Several homeodomain
transcription factors that are potential components of such a
regulatory cascade have since been identified in many other
organisms, including mammals (reviewed in refs. 3 and 4).
Recently, a family of transcription factors called the POU
family has been identified in mammals, in Caenorhabditis
elegans, and in Drosophila that, like the homeodomain
proteins, regulates various aspects of cell-fate specification
during development. Members of this family share two
homologous regions in their DNA binding domain: (i) a
60-amino acid homeodomain quite divergent from the clas-
sical Drosophila homeodomain, called the POU homeo-
domain, distinguished by the presence of Trp-Phe-Cys
(WFC) motif in the C-terminal domain of the DNA recogni-
tion helix; (ii) a 68- to 70-amino acid region that is unique to
this class of transcription factors referred to as the POU-
specific domain. These two regions together with a noncon-
served spacer region between them constitute the POU
domain (5).
The Oct factors are also members of the POU family of
transcription factors that bind to the octamer motif, a cis-
acting regulatory element found in the promoter and en-
hancer regions of several genes that are transcribed by both
RNA polymerase II and III (reviewed in ref. 6). Several Oct
transcription factors that are believed to play critical roles in
cellular development and differentiation have been identified
in mammals (7-16) and other vertebrates (17, 18). In contrast,
little is known about Oct factors from Drosophila. Here we
report the molecular cloning and spatial expression patterns
ofaDrosophila Oct gene.t We show that the protein encoded
by this gene is an octamer-dependent transcription factor that
activates transcription in the yeast Saccharomyces cerevi-
siae.
MATERIALS AND METHODS
Electrophoretic mobility-shift assays (19) using the consen-
sus octamer oligonucleotide probe (20), expression library
screening (21), and whole-mount in situ hybridizations (22)
were done as described.
Plasmid Constructs. The reporter plasmid pLGO4 was
constructed by cloning four copies of the consensus octamer
oligonucleotide at the unique Bgl II site upstream of the
TATA box in the pLGABS plasmid (23). To express the
dOctl and dOct2 in yeast, the cDNAs were cloned into the
yeast expression plasmid pAD4A (24).
Yeast Transformations and I3-Galactomkdase Assays. The
yeast strain SEY6210 (MATa, leu2-3-112, ura3-52, his3-
A200, trpl-A901, lys2-801, suc2-A9, met) was obtained from
Scott Emr (University of California, San Diego). Plasmids
were introduced into this strain as described (25) and colonies
were selected on minimal plates lacking uracil (to select for
pLGO4) or leucine (for pADOct2 or pADOctl) or both.
Twenty colonies were pooled from each transformation and
grown in minimal medium to an approximate OD600 of 1.0.
Cultures were collected by centrifugation and resuspended in
equal volumes of buffer Z; samples were lysed and assayed
as described (26).
RESULTS
Identification of Drosophila Oct (dOct) Factors. To identify
the presence of a nuclear factor that could specifically
interact with the octamer sequence motif, we carried out
electrophoretic mobility-shift experiments with crude embry-
onic nuclear extracts and the consensus octamer oligonucle-
otide. Fig. 1A shows that several protein-DNA complexes
were observed when nuclear extracts were incubated with
the labeled consensus oligonucleotide (lane 2). When excess
unlabeled competitor oligonucleotide was included in the
binding reaction mixture together with the labeled probe, all
the complexes showed a dose-dependent decrease in binding
(lanes 3-7). However, when challenged with a mutant com-
petitor oligonucleotide that carried point mutations in two
Abbreviation: 1-Gal, (3-galactosidase.
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tThe sequence reported in this paper has been deposited in the
GenBank data base (accession no. M93149).
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FIG. 1. Electrophoretic mobility-shift assay showing binding of
nuclear factors that interact with the consensus octamer binding site.
(A) Binding of Oct factors to the 32P-labeled wild-type octamer site
(lane 2) that can be blocked by competition with 10-, 20-, 30-, 50-, and
100-fold excess of unlabeled wild-type oligonucleotide (lanes 3-7).
Lane 1 is the control lane that contained only the probe and no
nuclear extract. (B) Binding reactions in the presence of 10-, 20-, and
50-fold excess of mutant oligonucleotide (lanes 3-5). (C) Binding in
the presence of 50-fold excess of oligonucleotides unrelated to the
octamer sequence (lanes 3 and 4). Lanes 1 and 2 in B and C are same
as lanes 1 and 2 in A. Asterisk indicates a nonspecific complex.
residues within the octamer consensus, only one complex
(indicated by an asterisk) disappeared completely even at the
lowest concentration of the competitor used (Fig. 1B, lanes
3-5). The other complexes remained relatively unaffected,
although there seemed to be a general decrease in the band
intensities. Similar results were obtained when totally unre-
lated oligonucleotides of similar sizes were used as compet-
itors (Fig. 1C, lanes 3 and 4). We believe that this complex is
due to the presence of a nonspecific DNA binding protein not
related to the Oct factors. Taken together, these data dem-
onstrate the presence of multiple nuclear factors that can
specifically bind to the consensus octamer sequence motif.
Isolation of cDNA Clones Encoding the dOct Genes. Having
confirmed the presence ofnuclear factors that interact with the
octamer motif, we screened a Drosophila embryonic (0-20 hr)
Agtll cDNA library using the wild-type octamer oligonucle-
otide. Two positive clones (of 6 x 105) were identified that
interacted with the wild-type octamer recognition site but not
with the nonspecific binding sites. Rescreening the same
library with a nick-translated cDNA probe yielded several
positive clones. Limited sequence analyses of the end regions
of the various subcloned cDNA inserts indicated that a ma-
jority of these positive clones constituted overlapping sets of
different cDNAs. One such set of three overlapping clones
represented the dOctl cDNA of -2.1 kilobases (kb). The
second set of another three overlapping clones constituted the
dOct2 cDNA of -2.2 kb. The complete nucleotide sequence
of 2190 base pairs of the dOct2 cDNA derived from a com-
posite of the overlapping cDNAs revealed a single open
reading frame that begins at position 174 and ends at position
1667 encoding a 498-amino acid polypeptide with a predicted
molecular mass of 54 kDa (Fig. 2a). However, in vitro trans-
lation experiments indicated that the dOct2 polypeptide mi-
grates as a 70-kDa species (Fig. 2b), presumably due to
anomalous mobility in SDS gels. dOct2 synthesized in vitro
was able to bind specifically to an octamer oligonucleotide
probe in a gel-shift assay (data not shown), suggesting that this
cDNA indeed encodes a Drosophila Oct factor.
Two other groups have recently reported the cDNA clon-
ing ofPOU domain-containing genes from Drosophila. These
cDNAs called pdm-1 and pdm-2 (28) and dPOU-19 and
dPOU-28 (29) are very closely related or identical, respec-
tively, to the dOctl and dOct2 sequences cloned by us.
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D46 FIG. 2. Nucleotide sequence of the
dOct2 cDNA and predicted amino acid
sequence of the encoded polypeptide in-
30 dicated the one-letter code. A putativepolyadenylylation signal in the nucleo-
tide sequence is underlined. The POU-
specific and the POU homeodomain are
indicated by the shaded and dark boxes,
21.5 respectively. (B) SDS/polyacrylamide
gel electrophoresis (27) of the products of
the dOct2 mRNA translation. Protein
markers are indicated in kDa.
However, no data have been reported concerning the DNA
binding or transcription activity of any of the polypeptides
encoded by the pdm or dPOU cDNAs. The sequences of
pdm-J and dPOU-19 are identical to each other and to dOctl.
Therefore, we do not present any data describing the se-
quence or the expression patterns of the dOctl gene. pdm-2
is identical to the dOct2 sequence from nucleotide position
372 to the end ofthe cDNA. However, the first 24 nucleotides
of the pdm-2 sequence show no homology to that of dOct2.
This deviation of the sequences is very likely due to the
presence of intronic sequences in the pdm-1 cDNA. dPOU-
28, on the other hand, is identical to the dOct2 sequence from
nucleotide position 1 of the dOct2 sequence but contains 12
additional nucleotides at the 5' end. However, the encoded
protein is presumed to be only 475 amino acids long as
compared to 498 amino acids of the presumptive dOct2 poly-
peptide. While the N termini of the two predicted proteins are
A
1 2 3 4 5 6 7
_
.
i
B a
* *
J"L."evelopmental Biology: Prakash et al.
91
1
III
4
271
34
361
64
452
94
S41
124
631
IS4
721
184
III
214
901
244
991
274
1061
304
1171
334
1261
364
13SI
394
1441
424
1531
04
1621
464
1711
1801
1191
1981
2071
2161
7082 Developmental Biology: Prakash et al.
identical, they differ only at their C termini. We believe that
this difference in the sequence of the two predicted polypep-
tides is due to a sequencing error in the dPOU28 cDNA. Both
dOctl and dOct2 (as well as pdm-1/pdm-2 and dPOU19/
dPOU28) map to a similar cytological position at band 33F.
Structure and Sequence Homology of the dOct2 Protein. A
search of the protein data base revealed a remarkable degree
of sequence identity in the POU domain between dOct2 and
several other Oct factors. Based on the extent of sequence
homology within this domain, Rosenfeld and coworkers (30,
31) have proposed a classification of the POU proteins into
five classes. According to this classification, dOct2 falls in the
type II class together with the Octl and Oct2 proteins and
shares 87-90% sequence identity at the amino acid level over
the entire POU domain (Fig. 3). Interestingly, a significantly
higher sequence conservation is observed in the POU-
specific (91-93%) than in the POU homeosubdomains (81-
86%). Within the POU homeodomain, however, the WFC
region that lies in the c-terminal one-third of the home-
odomain and comprises helix III, the recognition helix, is
absolutely identical in every member of this class. Certain
amino acid residues at which dOct2 differs from other mem-
bers of its class are especially noteworthy. Thus, for exam-
ple, the presence of a Gln residue instead of a Glu at position
26 in the B subdomain of the POU-specific domain appears
to be typical to only dOctl and dOct2. Similarly, the occur-
rence of a Cys residue in the hinge that connects helix I and
II ofthe POU homeodomain and two Ser residues at positions
5 and 8 in the second helix are unique to dOct2. While either
a Thr or an Ala residue is generally encountered at the fifth
position in most POU proteins, an Ala residue at position 8
is invariant in every member of the POU family.
Outside the POU domain, no significant homology is
observed between dOct2 and any other member of its class,
although just preceding and following this domain, only
dOctl and dOct2 share an identical stretch of 9 and 6 amino
acid residues, respectively. In the N-terminal region adjacent
to the POU domain, dOct2 is particularly rich in Gln (13%),
Ser (11%), Pro (11%), and Leu (10%) residues, a common
feature shared by several Drosophila transcription factors.
dOct2 Is a Transcription Activator. Since mammalian Oct
factors have been shown to function as transcription factors
(see ref. 6), we tested the possibility that the dOct proteins
could function as transcription factors as well. In Drosophila
tissue culture cells, a high level ofOct gene activity is observed
(E. Zandi and C.S.P., unpublished data), which contributes to
a significant level of background activity in transient trans-
fection assays. To minimize this background activity, we used
the yeast S. cerevisiae system. We first ensured that yeast do
not contain any octamer-dependent endogenous activity. To
do so, multiple copies of the consensus octamer oligonucleo-
tide were cloned upstream to the CYC1 promoter in the
plasmid pLGABS (23) that contains the CYC1 promoter
lacking its upstream activating sequence and is linked to the
bacterial,3-galactosidase (13-Gal) gene (24). As shown in Table
1, yeast cells that contain pLGABS or pLGO4 (containing the
octamer motif) show no detectable p-Gal activity, confirming
that yeast do not contain an activator that can utilize the
octamer motif. To test whether dOctl and dOct2 could func-
tion as trans-activators, we cloned the respective cDNAs into
the yeast expression vector pAD4A that contains the yeast
alcohol dehydrogenase promoter and termination signals (24).
Each of these constructs, called pADOctl and pADOct2, was
introduced into the yeast strain harboring pLGO4 and the
colonies obtained were assayed for /3-Gal activity. Cells that
harbor the pADOct2 and the pLGO4 plasmids show 89 units
of /-Gal activity (Table 1), suggesting that dOct2 is a strong
trans-activator that utilizes the octamer motif for its activity.
dOct2 was not able to induce any activity when the octamer
motifwas not present (in pLGABS; see Table 1). To verify that
the property to activate the pLGO4 plasmid is unique to
dOct2, we transformed yeast cells harboring the pLGO4 with
several control plasmids, including the parent plasmid pAD4A
and plasmids expressing other Drosophila transcription fac-
tors. None of these controls showed any measurable activity
(Table 1; data not shown). Also, dOct2 had no influence on the
activity ofthe intact CYC1 promoter from which the upstream
activating sequence (UAS) was not deleted (plasmid
pLG699Z; see Table 1). We conclude that dOct2 is an octamer-
dependent transcription activator.
dOctl, on the other hand, does not activate the reporter
gene efficiently. When expressed together with pLGO4, only
3.8 units of /3-Gal activity were measured (Table 1). It is
possible that dOctl, like the mammalian Octl, may require
additional coactivators to function efficiently. Mammalian
Octl functions as a transcriptional activator only in the
presence of the viral trans-activator, VP16, and another
cellular cofactor (37). Our preliminary data indicate that
VP16 does not cooperate with dOctl in yeast (data not
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FIG. 3. Comparison of the dOct2 POU domain with those of previously characterized POU domains. (A and B) Amino acid sequence
comparisons of the POU-specific and POU homeodomain regions of the POU proteins and dOct2, respectively. Darkly shaded regions indicate
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Table 1. dOct2 functions as an octamer-dependent transcription
factor in yeast
Trans- P-Gal
Plasmids in yeast Cis element activator activity*
pLGABS + pAD4A CYC1 promoter 1.0
pLGABS + pADOct2 CYC1 promoter dOct2 0.5
pLGO4 + pAD4A CYC1 promoter + 1.2
octamer sites
pLGO4 + pADOct2 CYC1 promoter + dOct2 89
octamer sites
pLG669Z + pAD4A CYC1 promoter 200
and enhancer
pLG669Z + pAdOct2 CYC1 promoter dOct2 225
and enhancer
pLGABS + pADOctl CYC1 promoter dOctl 0.5
pLGO4 + pADOctl CYC1 promoter + dOctl 3.8
octamer sites
pLG669Z + pADOctl CYC1 promoter dOctl 160
and enhancer
*Units per 107 cells. Shown is the average of at least three experi-
ments.
shown), suggesting that there could be different embryonic
coactivators that interact with dOctl.
Temporal and Spatial Expression Patterns of the dOct2
Gene. Northern blotting experiments with mRNA from dif-
ferent embryonic stages of development detected a single
transcript of 2.3 kb that hybridized with the dOct2 cDNA
probe (Fig. 4). While maximum levels ofthe dOct2RNA were
observed between 4 and 12 hr of development, low levels
were detected in 0- to 4-hr embryos and even lower levels
were observed in later development (16-24 hr). The size of
the dOct2 message detected in the RNA blots is in good
agreement with the size ofthe corresponding cDNA reported
here, suggesting that it is close to full length. As a control, the
blot was stripped and reprobed with the Drosophila tran-
scription factor TEIID cDNA. A single transcript of 1.6 kb
was detected that was almost constant in all the lanes (data
not shown) as was expected (38).
The spatial distribution of dOct2 mRNA was examined in
whole embryos by in situ hybridization. During the early
cellular blastoderm stage when theRNA first becomes detect-
able, dOct2 is expressed as a single broad band corresponding
to 20-40o ofthe egg length, very similar to that seen for dOctl
(unpublished data) (Fig. 5a). In addition, a dark speck of
expression is also observed at the anterior dorsal-most tip of
the embryo. Within a short interval, this broad band of
expression is lost and, instead, a complicated pattern of a
series of stripes appears (Fig. 5 b and c). While the stripes
anterior to the domain that corresponded to the broad band of
dOct2 expression appear de novo, the more posterior ones are
derived from the broad band of expression (Fig. 5c). The
striped expression is also transient and persists until the onset
of gastrulation. In early gastrulating embryos, this pattern is
followed by expression in 14 stripes, one in each parasegment,
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FIG. 4. Developmental North-
ern blot analysis of the dOct2 tran-
scripts. Poly(A)+ RNA isolated
from staged embryos (indicated as
hours after egg laying) was hybrid-
ized with dOct2 cDNA under stan-
dard conditions. The size of the
transcript was estimated by using
commercial RNA markers.
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until the extended germ band stage (Fig. 5d). Finally, dOct2 is
expressed in the brain and in a subset of the neuronal cells of
the central nervous system (Fig. 5 e-g). The 14-stripe expres-
sion pattern and the subsequent neuronal expression ofdOct2
message are reminiscent of the dOctl expression patterns
(unpublished data; refs. 28 and 29).
DISCUSSION
In this paper, we have described the identification and cDNA
cloning of an Oct gene from Drosophila. This gene is a
member of the class II type ofPOU genes that comprises all
of the known Octl and Oct2 genes. The remarkable evolu-
tionary conservation and extensive sequence homology in
the POU domain with previously known genes that are
involved in cell-fate specification suggest that this gene is
likely to be a component of one of the gene regulatory
networks that operates during Drosophila development. Our
most important observation is that the spatial patterns of
dOct2 expression transcend the domains of expression of the
classical Drosophila segmentation genes. To date, with the
exception of dOctl, we are not aware ofany other regulatory
gene in Drosophila whose spatial expression patterns cover
the entire spectrum of expression patterns that are seen for
each class of segmentation genes-i.e., the gap, pair rule, and
segment polarity genes. Thus, while the initial domain of
dOct RNA expression in a broad uniform band is surprisingly
similar (i.e., covering several segments), but not identical, to
some of the gap gene expression domains [for example, Kr
and knirps (reviewed in refs. 40 and 41)], the striped expres-
sion is comparable to a subset of stripes of the pair-rule class
[for example, hairy, even-skipped, and ftz (reviewed in ref.
42)]. Similarly, whereas the expression of the dOct genes in
14 narrower stripes is clearly reminiscent of the segment-
polarity genes [such as engrailed (43)], their expression in the
central nervous system parallels those of several of the gap,
segmentation, and homeotic genes (44-50). These data point
to possible functions for the dOct genes in segmentation
a
c
e
9
A
f.
b
d
2'. f
FIG. 5. Spatial distribution of dOct2 RNA during early embryo-
genesis. In situ hybridization of dOct2 cDNA to whole, wild-type
embryos was as described (22). Staging of the embryos was done as
described by Campos-Ortega and Hartenstein (39). All views are
lateral with anterior on the left unless otherwise stated. (A-) Stage
5, cellular blastoderm. (D and E) Stages 9 and 10, germ band
extension. (F) Stage 15, germ band retracted. dOct2 expression
appears in clusters of cells rather then in stripes. (G) Ventral view
showing expression in cells of the central nervous system.
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and/or in the initial events leading to the commitment of
some ectodermal cells to the neurogenic pathway. Given that
dOct2 is a transcription factor, it is reasonable to suggest that
a consequence of its expression either individually or in
combination with as yet unidentified transcription factors
contributes to the establishment of a combinatorial code for
segmentation and subsequent cellular differentiation.
Transcription activation in yeast has been used success-
fully to study various aspects of transcription by higher
eukaryotic proteins such as DNA recognition and oligomer-
ization, localization of activation domains, isolation of bind-
ing sites, and even to detect interacting proteins (see ref. 51
and refs. therein). Thus, the yeast system should provide an
ideal opportunity to identify and clone the genes that encode
distinct embryonic coactivators that may interact specifically
with dOctl. By transforming our yeast strain that harbors the
pADOctl and pLGO4 with an embryonic cDNA library, we
hope to clone the gene(s) that encodes a potential cofactor(s).
The availability of the cDNA clones should facilitate addi-
tional experiments in yeast and provide further insights into
the mechanisms of transcriptional regulation in early embry-
onic development.
Finally, the fact that dOct2 (and presumably dOctl) is a
transcription factor does not preclude its possible involve-
ment in DNA replication. Several transcription factors have
been shown to regulate DNA replication in viral systems (see
ref. 52 and refs. therein). In fact, both mammalian Octl and
Oct2 can stimulate the replication ofadenovirus DNA in vitro
(53, 54), presumably by facilitating the interaction of the
replication machinery with the origin of replication. Further-
more, data from in vivo experiments suggest that murine Oct3
and Oct6 may also be involved in DNA replication (13, 55).
In light of the highly dynamic expression patterns in early
embryonic development and because of their ability to dif-
ferentially respond to positional cues, it is tempting to
speculate that the Drosophila Oct factors might also contrib-
ute to cell type-specific differences in the regulation ofDNA
replication. Further genetic and biochemical experiments
should help elucidate the functions of the Oct genes during
Drosophila development.
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